Page last updated: 2024-12-05

diphenylborinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diphenylborinic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID17498
CHEMBL ID81556
SCHEMBL ID40601
MeSH IDM0130996

Synonyms (10)

Synonym
diphenyl borinic acid
CHEMBL81556 ,
diphenylborinic acid
bdbm50067889
borinic acid, diphenyl-
diphenyl-borinic acid
2622-89-1
SCHEMBL40601
DTXSID10180862
diphenylboric acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-lactamaseEscherichia coli K-12Ki100.00000.02703.64137.3000AID38398
Angiotensin-converting enzymeRattus norvegicus (Norway rat)Ki100.00000.00011.96427.3000AID38398
Calcium release-activated calcium channel protein 1Homo sapiens (human)IC50 (µMol)9.25000.50004.25009.8000AID749402; AID749403
Protein orai-2Homo sapiens (human)IC50 (µMol)9.25008.70009.25009.8000AID749402; AID749403
Protein orai-3Homo sapiens (human)IC50 (µMol)9.25004.00007.50009.8000AID749402; AID749403
Transient receptor potential cation channel subfamily V member 6Homo sapiens (human)IC50 (µMol)25.30009.40009.40009.4000AID749404; AID749405
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (20)

Processvia Protein(s)Taxonomy
antibiotic catabolic processBeta-lactamaseEscherichia coli K-12
response to antibioticBeta-lactamaseEscherichia coli K-12
store-operated calcium entryCalcium release-activated calcium channel protein 1Homo sapiens (human)
adaptive immune responseCalcium release-activated calcium channel protein 1Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayCalcium release-activated calcium channel protein 1Homo sapiens (human)
positive regulation of insulin secretionCalcium release-activated calcium channel protein 1Homo sapiens (human)
positive regulation of adenylate cyclase activityCalcium release-activated calcium channel protein 1Homo sapiens (human)
regulation of calcium ion transportCalcium release-activated calcium channel protein 1Homo sapiens (human)
positive regulation of calcium ion transportCalcium release-activated calcium channel protein 1Homo sapiens (human)
mammary gland epithelium developmentCalcium release-activated calcium channel protein 1Homo sapiens (human)
calcium ion importCalcium release-activated calcium channel protein 1Homo sapiens (human)
calcium ion transmembrane transportCalcium release-activated calcium channel protein 1Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathwayCalcium release-activated calcium channel protein 1Homo sapiens (human)
ligand-gated ion channel signaling pathwayCalcium release-activated calcium channel protein 1Homo sapiens (human)
store-operated calcium entryProtein orai-2Homo sapiens (human)
calcium ion transmembrane transportProtein orai-2Homo sapiens (human)
store-operated calcium entryProtein orai-3Homo sapiens (human)
calcium ion transmembrane transportProtein orai-3Homo sapiens (human)
calcium ion transportTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
regulation of calcium ion-dependent exocytosisTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
parathyroid hormone secretionTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
response to calcium ionTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
calcium ion homeostasisTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
beta-lactamase activityBeta-lactamaseEscherichia coli K-12
hydrolase activityBeta-lactamaseEscherichia coli K-12
calcium channel activityCalcium release-activated calcium channel protein 1Homo sapiens (human)
protein bindingCalcium release-activated calcium channel protein 1Homo sapiens (human)
calmodulin bindingCalcium release-activated calcium channel protein 1Homo sapiens (human)
store-operated calcium channel activityCalcium release-activated calcium channel protein 1Homo sapiens (human)
identical protein bindingCalcium release-activated calcium channel protein 1Homo sapiens (human)
protein bindingProtein orai-2Homo sapiens (human)
store-operated calcium channel activityProtein orai-2Homo sapiens (human)
protein bindingProtein orai-3Homo sapiens (human)
store-operated calcium channel activityProtein orai-3Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
outer membrane-bounded periplasmic spaceBeta-lactamaseEscherichia coli K-12
periplasmic spaceBeta-lactamaseEscherichia coli K-12
plasma membraneCalcium release-activated calcium channel protein 1Homo sapiens (human)
membraneCalcium release-activated calcium channel protein 1Homo sapiens (human)
basolateral plasma membraneCalcium release-activated calcium channel protein 1Homo sapiens (human)
plasma membrane raftCalcium release-activated calcium channel protein 1Homo sapiens (human)
membrane raftCalcium release-activated calcium channel protein 1Homo sapiens (human)
calcium channel complexCalcium release-activated calcium channel protein 1Homo sapiens (human)
membraneCalcium release-activated calcium channel protein 1Homo sapiens (human)
plasma membraneProtein orai-2Homo sapiens (human)
growth coneProtein orai-2Homo sapiens (human)
membraneProtein orai-2Homo sapiens (human)
plasma membraneProtein orai-3Homo sapiens (human)
membraneProtein orai-3Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
calcium channel complexTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID749402Inhibition of ORAl1/2/3 in HEK293 cells assessed as inhibition of Cd2+ influx after 10 mins by FLIPR assay in presence of thapsigargin2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Design, synthesis and pharmacological characterization of analogs of 2-aminoethyl diphenylborinate (2-APB), a known store-operated calcium channel blocker, for inhibition of TRPV6-mediated calcium transport.
AID749404Inhibition of human TRPV6 transfected in HEK293 cells assessed as inhibition of Cd2+ influx after 5 mins by FLIPR assay2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Design, synthesis and pharmacological characterization of analogs of 2-aminoethyl diphenylborinate (2-APB), a known store-operated calcium channel blocker, for inhibition of TRPV6-mediated calcium transport.
AID38398Inhibitory activity against Escherichia coli AmpC beta-lactamase.1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
AID749405Inhibition of human TRPV6 transfected in HEK293 cells assessed as inhibition of Ca2+ influx after 5 mins by FLIPR assay2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Design, synthesis and pharmacological characterization of analogs of 2-aminoethyl diphenylborinate (2-APB), a known store-operated calcium channel blocker, for inhibition of TRPV6-mediated calcium transport.
AID749403Inhibition of ORAl1/2/3 in HEK293 cells assessed as inhibition of Ca2+ influx after 10 mins by FLIPR assay in presence of thapsigargin2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
Design, synthesis and pharmacological characterization of analogs of 2-aminoethyl diphenylborinate (2-APB), a known store-operated calcium channel blocker, for inhibition of TRPV6-mediated calcium transport.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (16.67)18.7374
1990's4 (33.33)18.2507
2000's0 (0.00)29.6817
2010's6 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.30 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.23 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]